Arne Astrup – Københavns Universitet

Videresend til en ven Resize Print Bookmark and Share

Mad og drikke > Deltagere > Arne Astrup

Arne Vernon Astrup

Institutleder, professor,overlæge.
dr. med. Medleder af projektet
”Mad drikke og tobak i Danmark
i det 19. århundrede”.
Arne Vernon Astrup


Institut for Human Ernæring, Den kgl. Veterinær- og Landbohøjskole, Rolighedsvej 30, DK-1958 Frederiksberg C.
Telefon: +45 35282476.
Email: arne@arne-v-astrup.dk.
 


Publikationer:
 

  • Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes 2003;27:147-61.
  • Sørensen LB, Flint A, Raben A, Hartmann B, Holst JJ, Astrup A. No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy expenditure in normal weight subjects. Int J Obes 2003;27:450-6.
  • Jessen AB, Toubro S, Astrup A. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilisation in men. Am J Clin Nutr 2003;77:1442-7.
  • Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing conjugated linoleic acid (CLA) for the treatment of obesity-evidence from animal and human studies. J Lipid Res. 2003 Aug 16
  • Larsen TM, Toubro S, van Baak MA, Gottesdiener KM, Larson P, Saris WHM, Astrup A. Effect of 28-d treatment with L-796568, a novel ?3-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr 2002;76:780-8.
  • Hansen DL, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rössner S, Saris WHM, van Gaal LF, James WPT, Goulder M for the STORM study group. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-center STORM trial. Int J Obes 2001;25:496-501.
  • Verdich C, Flint A, Gutzwiller J-P, Näslund E, Beglinger C, Hellström PM, Long SJ, Morgan LM, Holst JJ, Astrup A. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrin Metab 2001;86:4382-9.
    Flint A, Raben A, Rehfeld JF, Holst JJ, Astrup A. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. Int J Obes 2000;24:288-298.
  • Astrup A, Rössner S. Lessons from obesity management programmes: Greater initial weight as an integrated part of an obesity management program improves long-term maintenance. Obesity Reviews 2000;1:17-19.
  • Buemann B, Toubro S, Astrup A. Effects of the two $3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects. Int J Obes 2000;24:1553-60.
  • James WPT, Astrup A, Finer N, Hilsted J, Kopelman P, Rössner S, Saris WHM, van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000;356:2119-25.

    Yderligere oplysninger:

    www.arne-v-astrup.dk